Neuralink
Latest round
- Series E
Last raised
- May 2025
Total raised
- $1.2B
Investors
- 15
About Neuralink
Founded in 2016 and based in Fremont, CA, Neuralink Corp. focuses on developing advanced brain-computer interface (BCI) technologies that allow individuals with severe neurological conditions to control devices through thought alone. The company was founded by Elon Musk along with DJ Seo, Kiwoba Allaire, and Max Hodak, with Arjang Zandnia and Baris Aydeniz who all currently occupy executive roles within the company. In July 2025, Neuralink Corp. Neuralink's core offerings center around its brain-computer interface (BCI) technology that translates neural signals into actionable commands. This innovative solution enables individuals with severe neurological conditions, such as spinal cord injuries and amyotrophic lateral sclerosis (ALS), to interact with computers and control robotic limbs using their thoughts. The devices, implanted through minimally invasive surgical techniques, are currently being utilized in various clinical trials, demonstrating their effectiveness in restoring autonomy to users. The primary clientele includes patients with unmet medical needs, caregivers, and healthcare providers, primarily in North America and Europe, where the technology is being tested and implemented. Additional efforts are aimed at expanding the geographical reach of these solutions to other regions as the technology advances and regulatory approvals are obtained. Neuralink's revenue model is structured around the commercialization of its BCI technology, primarily through clinical trials and eventual sales to healthcare institutions and end-users. The transactions involve the provision of implantable devices and associated services directly to clients, which include hospitals and rehabilitation centers. Revenue is generated as these institutions procure Neuralink’s products for clinical and therapeutic applications. The pricing structure for individual devices and the associated services is designed to align with existing medical technology pricing standards, yet specific pricing details are proprietary. As the company advances its technology and gains regulatory approvals, it is expected to expand into direct-to-consumer sales, thereby broadening its revenue streams. Upcoming products are focused on enhancing device capabilities, with plans for a launch in the coming years pending regulatory approvals.
Who invested in Neuralink
15 investors across 4 rounds
See all investors in Neuralink
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neuralink
Who invested in Neuralink?
Neuralink has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuralink raised?
Neuralink has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuralink last raise money?
Neuralink's most recent round on record is a Series E, in May 2025.
What does Neuralink do?
Founded in 2016 and based in Fremont, CA, Neuralink Corp.
Where is Neuralink headquartered?
Neuralink is headquartered in Fremont, US.
Which VCs invest in companies like Neuralink?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Neuralink's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Neuralink? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.